Clyman RI, Liebowitz M, Johnng S, Clyman RI, Hills NK. Relationship between the duration of infantile exposure to moderate to large-scale patented ductal myocardial muscles and the risk of developing bronchopulmonary dysplasia or death 36 weeks prior. AM J Perinatol. 2020; 37:216–23.
Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure to ductus arteriosus occlusion is associated with increased mortality in preterm infants. Pediatrics. 2009; 123: E138–44.
Association between hemodynamically significant patented intraductal arteries and bronchopulmonary dysplasia, including Schena F, Francescato G, Cappellli A, Picciolli I, Mayer A, and Mosca F. J Pediatr. 2015; 166:1488–92.
HärkinP, Marttila R, Pokka T, Saarela T, Hallman M. Pathological conditions associated with patented milk ducts in preterm infants. National Cohort Study. J Matern Fetal Neonatal Medicine. 2018; 31:2576–83.
Trials for selective early treatment of the ductus arteriosus with ibuprofen, including Gupta S, Subhedar NV, Bell JL, Field D, Bowler U, and Hutchison E. N Engl J Med. 2024; 390:314–25. https://doi.org/10.1056/nejmoa23055826.
Predictive management or early ibuprofen of patent hemorrhagic arteries including Hundscheid T, Onland W, Kooi EMW, Vijlbrief DC, De Vries WB, Dijkman KP. N Engl J Med. 2023; 388:980–90.
Giesinger RE, Hobson AA, Bischoff AR, Klein JM, McNamara PJ. Effects of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” weeks and “24-26” infants. Seminperinatol. 2023; 47:151721.
Patented ductal shunt removal, including Bussmann N, Smith A, Breatnach CR, McCallion N, Cleary B, Franklin O, results in reduced adverse outcomes: Post hoc analysis of PDA RCT cohort. J Perinatol. 2021; 41:1134–41. https://doi.org/10.1038/S41372-021-01002-Z.
Bravo MC, Sánchez-Salmador R, Moral-Pumarega MT, López-Azorín M, Mosqueda-Peña R, Dorronsoro I, et al. Randomized trials of echocardiographically induced ductus arteriosus therapy to reduce necrotic enteritis. Frontpedia Tor. 2022; 9:807712.
El-Khuffash A, Bussmann N, Breatnach CR, Smith A, Tully E, Griffin J, et al. A pilot randomized controlled trial of early-targeted patent duct arterial therapy using risk-based severity scores (PDA RCTs). J Pediatr. 2020. https://doi.org/10.1016/j.jpeds.2020.10.024.
Patented intraductal artery severity scores such as El-Khuffash A, James AT, Corcoran JD, Dicker P, Franklin O, and Elsayed YN predict chronic pulmonary disease or death before discharge. J Pediatr. 2015; 167:1354–61.
Bravo MC, Sánchez R, Blanco AI, Losantos I, Pellicer A. A predictive model of early spontaneous artery occlusion based on neonatologists was performed echocardiography in preterm infants. Frontpedia Tor. 2021; 9:1–8.
Mitra S, de Boode WP, Weisz de, Shah PS. Ductal arteriosus (PDA) interventions in preterm infants: An overview of a systematic review of Cochrane. Cochrane Database Syst Rev. 2023; 4: CD013588. https://doi.org/10.1002/14651858.cd013588.pub2.
Bravo MC, Jiménez R, Parrado-Hernández E, Fernández JJ, Pellicer A. Predict the efficacy of drugs used to treat cardiovascular conditions in newborns. Pediatr res. 2024; 95:1124–31.
Sammut SJ, Crispin-Ortuzar M, Chin SF, Provenzano E, Bardwell HA, Ma W, et al. Multi-Omicus machine learning predictors of breast cancer therapy response. Nature. 2022; 601:623–9.
Moon I, Lopiccolo J, Baca SC, Sholl LM, Kehl KL, Hassett MJ, and others Machine learning for genetic classification and predicting treatment response in unknown primary cancers. Nut Med. 2023; 29:2057–67. https://doi.org/10.1038/S41591-023-02482-6.
Dhillon SK, Ganggayah MD, Sinnadurai S, Lio P, Taib Na. Theory and practice that integrates machine learning and traditional statistics in medical data analysis. diagnosis. 2022; 12:2526.
Liu TX, Zheng JX, Chen Z, Zhang ZC, Li D, Shi LP. An interpretable machine learning model to predict the efficacy of nonsteroidal anti-inflammatory drugs to close hemodynamically significant patented arterial bones in preterm infants. Frontpedia Tor. 2023; 11:1097950.
García-Martín E, Martínez C, Tabarés B, Frías J, Agúndez Jag. Interpersonal variation in ibuprofen pharmacokinetics is associated with the interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms. Clin Pharm Ther. 2004; 76:119–27. Available at https://askpt.onlinelibrary.wiley.com/doi/abs/10.1016/j.clpt.2004.04.006
Fumagalli M, Parodi A, Ramenghi L, Limperopoulos C, Steggerda S, Agut T, et al. Ultrasound of acquired posterior fossa abnormalities in newborns. Pediatr res. 2020; 87:25–36.
Cranial ultrasound findings in preterm embryonic matrix bleeding, sequelae and outcomes, including Parodi A, Govaert P, Horsch S, Bravo MC, Ramenghi LA, and Agut T. Pediatr res. 2020; 87:13–24.
Damage of preterm births including Agut T, Alarcon A, Cabañas F, Bartocci M, Martinez-Biarge M, Horsch S: Ultrasound diagnosis and classification. Pediatr res. 2020; 87:37–49.
Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent report of multivariable predictive models for individual prognosis or diagnosis (tripod): a tripod statement. Unintern Med. 2015; 162:55–63.
Cakmak A, Ayaz H, Arıkan S, Ibrahimzada AR, Demirkolş, SönmezD, et al. Predict predisposition to colorectal cancer based on immunophenotype SNP profiles using monitored learning models. Med Biol Eng Comput. 2023; 61:243–58.
Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, etc. Indomethacin prevention, ductus arteriosus patents, and risk of bronchopulmonary dysplasia: further analysis from trials of indomethacin prevention in preterm birth (TIPP). J Pediatr. 2006; 148:730–4.
Chen X, Han D, Wang X, Huang X, Huang Z, Liu Y, et al. Vascular and pulmonary effects of ibuprofen on neonatal lung development. Respir Res. 2023; 24:39.
McAdams RM, Kaur R, Sun Y, Bindra H, Cho SJ, Singh H. Prediction of clinical outcomes using artificial intelligence and machine learning for neonatal intensive care units: a systematic review. J Perinatol. 2022; 42:1561–75.
Comparison of artificial intelligence models for patented ductal duct analysis of ductus arteriosus in very low birthweight infant cohorts across the country. SciRep. 123ad; 11:22353. Available at www.nature.com/scientificreports.
Challen R, Denny J, Pitt M, Gompels L, Edwards T, Tsaneva-Atanasova K. Artificial Intelligence, Bias and Clinical Safety. Vol. 28, BMJ quality and safety. BMJ Publishing Group; 2019. p. 231–7.
Moronta SC, Bischoff AR, Ryckman KK, Dagle JM, Giesinger RE, McNamara PJ. Clinical and echocardiographic predictors of response to first-line acetaminophen treatment in preterm infants with hemodynamically significant patent arterial muscles. J Perinatol. 2024; 44:379–87.
Green CA, Westreich D, Laughon MM, Stamilio DM, Strauss RA, Reese J, Association of Villinotropic Onoccultitis and Patented Intraductal Artery Bureaus in a Cohort of Other National US. J Perinatol. 2021; 41:119–25.
Park HW, Choi YS, Kim KS, Kim SN. Choriotitis and patent ductitis: a systematic review and meta-analysis. PLOS 1. 2015; 10: E0138114.
Del Moral T, Gonzalez-Quintero VH, Claure N, Vanbuskirk S, Bancalari E. Prenatal exposure to magnesium sulfate and incidence of patented ducts in very low birth weight infants. J Perinatol. 2007; 27:154–7.
Effects of magnesium sulfate exposure to ductus arteriosus ducts in preterm infants. AM J Perinatol. 2024; 41:1665–72. https://doi.org/10.1055/S-0044-1779620.
Katayama Y, Minami H, Enomoto M, Takano T, Hayashi S, Lee YK. Postnatal response of the ductus arteriosus to magnesium sulfate and indomethacin in very preterm neonates. J Perinatol. 2011; 31:21–4.
Richardson DK, Corcolan JD, Escobar GJ, Lee SK. Snap-II and Snappe-II: Simplified neonatal disease severity and death risk scores. J Pediatr. 2001; 138:92–100. Available at https://www.sciencedirect.com/science/article/pii/S0022347601516017.
